Poster Display Immune dysregulation & autoimmunity

VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE SECONDARY TO XIAP DEFICIENCY

Lecture Time
10:59 - 11:00
Presenter
  • Elif Soyak Aytekin, Turkey
Room
Poster Area
Date
19.09.2019, Thursday
Session Time
10:00 - 17:00
Board Number
122
Presentation Topic
Immune dysregulation & autoimmunity

Abstract

Background and Aims

Introduction

The X-linked inhibitor of apoptosis (XIAP) deficiency, also known as the X-linked lymphoproliferative syndrome type 2 (XLP-2) , is rare primary immunodeficiency.We report a patient who had XIAP gene defect and presented with very early onset inflammatory bowel disease and recurrent hemophagocytic lympohistiocytosis (HLH).

Methods

Case Report

The patient who had chronic diarrhea and history of HLH was referred to our hospital for further evaluation at 8 months of age. Chronic diarrhea was started when he is 40 days old and he suffered from a HLH episode at two months of age.

In his follow up ,bone marrow aspiration was done due to prolonged fewer and hemophagocytosis was detected. Pulse methylprednisolone (mpz) and intravenosus immunoglobulin( 400 mg/kg/day) was administered. We continued with 1mg/kg mpz colonoscopy revealed , multiple, lineer ulcers covered with white membranes in the rectum.

Results

In the follow-up we performed next generation sequencing analysis for primary immunodeficiency diseases, and a homozygous c.518G>A (p.Trp173Ter) XIAP gene defect was found.

Conclusions

XIAP deficiency should be considered in patients presenting with very early onset inflammatory bowel disease and recurrent HLH. Early diagnosis and hematopoietic stem cell treatment will decrease the risk of life threatening complications.

Hide